1. An epigenetic mechanism for tamoxifen-associated uterine carcinogenesis?;Carmichael;Eur. J. Cancer,1998
2. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment;Butta;Cancer Res.,1992
3. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor b receptor therapy;Won;Cancer Res.,1999
4. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium;Gold;Cancer Res.,1994